Bouchekioua et al. have reported that activation of the JAK3/STAT3 pathway exerts major activity in ENKTL cell growth and survival; whereas tumor growth could be significantly suppressed by a JAK inhibitor [45]. This evidence concerns the gene JAK3 and neoplasm.